Other prognostic factors: Imaging

Among the various imaging techniques used in myeloma, whole-body magnetic resonance imaging (MRI) provides the most useful prognostic information. Several studies have shown that the pattern of myeloma cell infiltration of the bone marrow and the number of focal lesions both correlate with the ISS staging system and survival. Earlier detection can also help to prevent irreversible structural damage.

MRI can also accurately stage solitary bone plasmacytoma, predict the progression of smouldering myeloma, and determine response to treatment. As MRI scanning becomes more widely available, it may in future be very useful in helping to determine prognosis and response to treatment.

Further reading

Hughes et al. (2024) Diagnosis and management of smouldering myeloma: A British Society for Haematology Good Practice Paper. Br J Haematol. 2024;204:1193–1206.

Kaiser et al., (2024) Advanced imaging for earlier diagnosis and morbidity prevention in multiple myeloma: A British Society of Haematology and UK Myeloma Society Good Practice Paper. Br J Haematol. 2024;205:1319–1325.

Messiou & Kaiser (2018) Whole-Body Imaging in Multiple Myeloma. Magn Reson Imaging Clin N Am. 26(4):509-525.